New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]
AngioDynamics
AngioDynamics shares rise on Q3 EPS beat
Shares in AngioDynamics (NSDQ:ANGO) rose today after the medical device maker topped earnings per share expectations on Wall Street with its 3rd quarter earnings. The Albany, N.Y.-based company posted profits of $2.9 million, or 8¢ per share, on sales of $85.6 million for the 3 months ended Feb. 28, for massive bottom-line growth of 386% while […]
AngioDynamics wins CE Mark for Solero microwave tissue ablation system
AngioDynamics (NSDQ:ANGO) said today it won CE Mark approval in the European Union for its Solero microwave tissue ablation system, with indications for ablation of soft tissue during open, laparoscopic or percutaneous procedures. The Albany, N.Y.-based company’s Solero MTA system features a 2.45GHz microwave generator with an operating frequency up to 140 watts and a ceramic […]
AngioDynamics posts Q2 earnings
Shares in AngioDynamics (NSDQ:ANGO) rose today after the medical device maker met expectations on Wall Street with its fiscal 2nd quarter results. The Albany, N.Y.-based company posted profits of $45 million, or 37¢ per share, on sales of $89 million for the 3 months ended Nov. 30, for bottom-line loss of -2% on sales loss of […]
AngioDynamics to buy back $8m stake in secondary offering
AngioDynamics (NSDQ:ANGO) today priced a secondary offering, saying it plans to repurchase $8 million in shares itself from the round. The Albany, N.Y.-based company said the round should bring in a total of $40 million through the sale of 2.5 million shares at $16 per share, all offered by selling stockholders. AngioDynamics said it plans to […]
AngioDynamics shares droop despite swing to Q1 black
AngioDynamics (NSDQ:ANGO) reported its 1st quarter results for fiscal 2017 yesterday, posting a 5% top-line gain and a swing to black ink. Despite the good news, ANGO shares closed down more than 6% yesterday, but recovered somewhat today. The Latham, N.Y.-based company reported profits of $1.3 million, or 4¢ per share, on sales of $88.1 million for the 3 […]
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel Moves, July 28, 2016
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as well as managing the entire company’s U.S. sales and service center. Mazzo comes from a 3-year run as president and CEO at AcuFocus, where […]
UPDATE: Stryker recalls select re-sterilized AngioDynamics Soft-VU angio caths
Updated to include comment from Stryker and to adjust “reprocessed” language to “re-sterilized” Stryker‘s (NYSE:SYK) Sustainability Solutions biz said it recalled a select number of re-sterilized AngioDynamics (NSDQ:ANGO) Soft Vu omni flush angiographic catheters due to reports of tip separation. AngioDynamics said it is not associated with the recall, and that the devices affected have their own […]
Schellhorn out, Emerson in as Monteris CEO | Personnel Moves July 25, 2016
Schellhorn out, Emerson in as Monteris CEO Monteris Medical said last week it tapped ex-Galil Medical prez & CEO Martin Emerson as its new president and chief executive officer, replacing John Schellhorn who left earlier this year. Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year […]
AngioDynamics jumps on Street-beating Q4 earnings
AngioDynamics (NSDQ:ANGO) shares jumped today after the company reported fiscal 4th-quarter and 2016 results that beat Wall Street’s consensus forecast. The Latham, N.Y.-based company posted losses of -$44.0 million, or -$1.21 per share, on sales of $93.4 million for the 3 months ended May 31, for a top-line gain of 2.7%. And although losses widened by some 5,300% […]
Appeals court denies Biolitec in Angiodynamics spat
The 1st Circuit Court last week denied German medical laser maker Biolitec‘s (ETR:BIB) challenge to a Massachusetts federal court ruling which found for AngioDynamics (NSDQ:ANGO) and set possible contempt sanctions against Biolitec. The ruling is the most recent in a long-running spat between the 2 companies. Biolitec reportedly violated a preliminary injunction and appealed the resulting civil […]